Differentiating Polymyalgia rheumatica from other diseases: Difference between revisions

	Polymyalgia Rheumatica Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Polymyalgia rheumatica from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Differentiating Polymyalgia rheumatica from other diseases On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Differentiating Polymyalgia rheumatica from other diseases All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Differentiating Polymyalgia rheumatica from other diseases
CDC on Differentiating Polymyalgia rheumatica from other diseases
Differentiating Polymyalgia rheumatica from other diseases in the news
Blogs on Differentiating Polymyalgia rheumatica from other diseases
Directions to Hospitals Treating Polymyalgia rheumatica
Risk calculators and risk factors for Differentiating Polymyalgia rheumatica from other diseases

VisualWikitext

Revision as of 15:47, 8 May 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Polymyalgia rheumatica (PMR) must be differentiated from other conditions such as late onset rheumatoid arthritis, polymyositis, dermatomyositis, fibromyalgia, and remitting seronegative symmetrical synovitis with pitting edema.

Differentiating Polymyalgia Rheumatica from other Diseases

PMR must be differentiated from the following conditions:

Rheumatoid arthritis: PMR and late onset rheumatoid arthritis (RA) can initially present with similar clinical features like synovitis. These patients are treated initially as PMR with glucocorticoids. RA treatment is started when there is no improvement or when it evolves into characteristic RA or when there is a persistently raised plasma viscosity.^[1] ^[2]

Polymyositis and dermatomyositis: Patients with dermatomyositis or polymyositis present with tenderness and weakness of proximal muscles, while PMR patients present with pain and stiffness. This differentiation between these entities may be difficult in elderly patients. Proper history, complete physical examination, ESR, creatine kinase levels and muscle biopsy help in establishing the proper diagnosis.^[3] ^[4]

Malignancy (such as myeloma): Patients with malignancy sometimes present with PMR like symptoms and have poor response to steroid therapy.^[5] This is in fact paraneoplastic syndrome presenting as PMR.^[6]

Fibromyalgia: Fibromyalgia occurs in age groups 20-50 years. Patients have characteristic tender points. Unlike PMR, the active phase proteins and ESR are normal.

Hyperparathyroidism: Hyperparathyroidism presents with proximal stiffness and bone pain with elevated parathyroid hormone levels and often raised calcium levels without elevation of ESR levels.

Chronic infection (subacute bacterial endocarditis (SBE)): Rheumatologic symptoms seen in infective endocarditis can present as a clinical picture suggestive of polymyalgia rheumatica hindering the correct diagnosis.^[7]

Hypothyroidism: Patients with hypothyroidism muscle and joint pain and weakness similar to PMR. Delayed relaxation of deep tendon reflexes is seen in hypothyroidism with elevated TSH levels and low T4 levels.

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): RS3PE presents with symmetrical synovitis and pitting edema, usually in patients over 50 years of age and lack rheumatoid factor. Unlike PMR, the symptoms commonly manifest distally.

Differentiating polymyalgia rheumatica on the basis of fatigue and chronic pain

Disease	Differentiating signs and symptoms	Diagnostic findings
Polymyalgia rheumatica	Older at onset Generalized stiffness	An elevated erythrocyte sedimentation rate (ESR) OR C-reactive protein (CRP) Response to corticosteroids
Fibromyalgia	Symptoms have been present at a similar level for at least 3 months. Chronic musculoskeletal pain with multiple tender points Stiffness, numbness, and fatigue Headaches Sleep disorder	All lab tests are normal
Rheumatoid arthritis	Multiple joint swelling Morning stiffness Rheumatoid nodules	RF or anti-cyclic citrullinated protein (CCP) antibody is positive. Markers of systemic inflammation (ESR, CRP) are typically elevated.
SLE	Maculopapular rash Multi-system involvement	Positive anti-Smith antibodies
Chronic fatigue syndrome	Fatigue plus 4 of the following symptoms: Short-term memory loss Sore throat Tender lymph nodes in the neck or armpit Muscle pain Joint pain without swelling or redness Headaches Insomnia Malaise	Diagnosis of exclusions Symptoms must present for more than 6 months
Spondyloarthritis	Axial skeletal pain and stiffness Restricted spinal motion	Elevated ESR or CRP Negative RF Bamboo spine on x-ray
Osteoarthritis	Localized joint pain Restricted to affect joints Older at onset	X-ray of the involved joints demonstrate degenerative changes
Hypothyroidism	Systemic symptoms such as weight gain, constipation, dry skin Muscular aching and prominent fatigue that improves on replacement of thyroid hormone.	TSH is elevated and free T4 is low.
Myopathaies (polymyositis and dermatomyositis)	Pelvic and shoulder girdle muscle weakness Rash	Muscle biopsy confirms the diagnosis Elevated CPK enzyme
Neuropathy	Numbness and tingling Paresthesia	Abnormal EMG

Differentiating polymyalgia rheumatica from other causes of myopathy

Organ system	Disease	Symptoms												History	Physical Examination	Diagnosis
Organ system	Disease	Age of onset	Muscle weakness	Fever	Myalgia	Contractures	Gait abnormality	Neuropathy	Atrophy	Stiffness	Myoglobinuria	Other features	Laboratory Findings	History	Physical Examination	Creatine Kinase	Muscle Biopsy	Electromyogram
Medication−induced	Corticosteroids^[8]	Variable	Proximal	−	+	−	−	−	+	−	−	Central obesity Excessive sweating Insomnia Reduced libido Amenorrhea Infertility Psychological disturbances	Positive h/o medications	Facial and sphincter muscles are usually spared	Positive ACTH stimulation test 24-hour urine cortisol Low dose dexamethasone suppression test	Normal	Normal	Normal
	Statins^[9]	60+	Proximal	−	+	−	−	−	−	−	−/+(Rhabdomyolysis)	N/A	Positive h/o medications H/o other medication use	Tenderness Muscle aches	↑↑ Liver enzymes	↑↑	Necrosis Degeneration, and regeneration of fibers Phagocytic infiltration	Normal
	Alcohol^[10]	Variable	Proximal	−	−	−	+	+/−	−	−	−	Swelling Tender Erythema and induration	Alcohol intoxication	Change in mental status Telangiectasia Peripheral neuropathy	Monspecific and are normal in many patients	Normal or ↑↑	Normal	Normal
Organ system	Disease	Age of onset	Muscle weakness	Fever	Myalgia	Contractures	Gait abnormality	Neuropathy	Atrophy	Stiffness	Myoglobinuria	Other features	History	Physical Examination	Laboratory Findings	Creatine Kinase	Muscle Biopsy	Electromyogram
Endocrine	Cushing's disease^[11]	25 −45	Proximal	−	−	−	−	−	+	−	−	Decreased libido Obesity/weight gain Plethora Round face Menstrual changes Hirsutism Hypertension Ecchymoses Lethargy Depression Dorsal fat pad Abnormal glucose tolerance	N/A	Facial and sphincter muscles are usually spared Overweight Straie Moon face HTN Hyperpigmentation	Positive ACTH stimulation test 24-hour urine cortisol Low dose dexamethasone suppression test	Normal	Atrophy of type 2 muscle fibers, especially type 2B	Normal
	Adrenal insufficiency^[12]	30−50 years	Proximal	−	+	−	−	−	−	+	−	Signs of glucocorticoid, mineralocorticoid, and, androgen deficiency	Signs of postural hypotension History of tuberculosis History of malignancy History of other autoimmune disease	Hypotension Hyperpigmentation Auricular−cartilage calcification Vitiligo	Electrolyte abnormalities Hypoglycemia	Normal	Normal	Normal
	Hyperaldosteronism with myopathy^[13]	50	Proximal & distal	−	−	−	−	−	−	−	+ Rhabdomyolysis	Palpitations Hypertension	Episodes of increased heart beats	Hyperpigmentation	Hypokalemia	Normal	Normal	Normal
	Hyperthyroidism^[14]	40	Proximal	−	−	−	−	−	+	+	+	Signs of hyperthyroidism	H/o of weight loss	Sweating Tremor Neck swelling	Decreased TSH	↑↑	Non specific	Myotonic
	Hypothyroidism^[15]	55	Proximal	−	+	+	−	−	+	+	+ Rhabdomyolysis	Signs of hypothyroidism	H/o weight gain	Myxoedema Muscle pseudohypertrophy	Increased TSH	↑↑	Nonspecific	Normal
	Diabetic infraction^[16]	45	Proximal	+	+	−	−	+	+	−	−	Cramps Sudden onset of pain Anterior thigh muscles are most commonly involved	H/O long standing diabetes	Swelling Tenderness	Elevated ESR Leukocytosis	Normal	Necrosis Edema	Normal
Organ system	Disease	Age of onset	Muscle weakness	Fever	Myalgia	Contractures	Gait abnormality	Neuropathy	Atrophy	Stiffness	Myoglobinuria	Other features	History	Physical Examination	Laboratory Findings	Creatine Kinase	Muscle Biopsy	Electromyogram
Inflammatory/ Rheumatologic	Dermatomyositis^[17]	40s−50s Can affect children	Proximal	+	+	−	−	−	−	+	−	Rash Dyspnea Weight loss Cough	Viral infections Cancer	Heliotrope rash on face and hands Telangiectasia Erythema Mechanic's hands Gottron's sign ( violaceous scaly eruption )	↑↑ ESR ↑↑ CRP	↑↑	Perimysial mononuclear infiltrate	Myopathic
	Polymyositis^[18]	> 18 years	Proximal	+	+	−	−	−	−	+	−	Similar to dermatomyositis without mucous and skin involvement	N/A	N/A	↑↑ ESR ↑↑ CRP	↑↑	Endomysial mononuclear infiltrate Patchy necrosis	Myopathic
	Inclusion body myositis^[19]	50s	Proximal & distal	−	−	−	−	−	−	−	−	Dysphagia Asymmetric weakness	Retrovirus (most common)	N/A	Antibodies to cytoplasmic 5'−nucleotidase	↑↑	Inflammatory cells Invading muscle cells Vacuolar degeneration Inclusions or plaques	Neurogenic
	Fibromyalgia^[20]	40−50s	Generalized	−	−	−	−	+	−	−	−	Anxiety or depression features Fatigue Sleep disturbance Numbness Muscle spasms	History of depression	Tenderness in the soft tissue anatomical location	Normal	Normal	Normal	Normal
	Polymyalgia Rheumatica^[21]	50s	Diffuse	+	+	−	−	−	−	+	−	Weight loss	History of joints stiffness, worse in the morning	Restricted shoulder motion	↑↑ ESR ↑↑ CRP	Normal	Normal	Normal
Organ system	Disease	Age of onset	Muscle weakness	Fever	Myalgia	Contractures	Gait abnormality	Neuropathy	Atrophy	Stiffness	Myoglobinuria	Other features	History	Physical Examination	Laboratory Findings	Creatine Kinase	Muscle Biopsy	Electromyogram
Genetic	Becker muscular dystrophy^[22]	<13yrs	Proximal	−	−	+	+	−	+	−	−	Milder form of Duchenne	Growth delay Age of onset of symptoms is much delayed than duchenne	Positive Grower sign	Decreased amount of dystrophin.	↑↑	Muscle fibril degeneration, regeneration Isolated fiber hypertrophy Muscle replacement with fat and connective tissue	Myopathic
	Duchenne muscular dystrophy^[23]	<13 yrs	Proximal	−	−	+	+	−	+	−	−	Calf psedohypertrophy Cardiomyopathy Kyphoscoliosis Cognitive impairment	Early onset	Positive Grower sign	Errors in the Xp21 gene. Absence of dystrophin.	↑↑		Myopathic
	Limb−girdle muscular dystrophies^[24]	<15 yrs	Proximal	−	+	+	+	−	+	−	−	Calf hypertrophy Scapular winging Cardiomyopathy Cardiac arrhythmias Respiratory muscle weakness	Autosomal dominant Deterioration of ability to run/walk	Muscle weakness is generally symmetric	LMNA gene CAV3 gene	↑↑	N/A	Myopathic
	Myotonic dystrophy^[25]	<18 years	Proximal & distal	−	−	+	+	−	−	+	−	Myotonia Cataracts Diabetes mellitus Frontal balding Cardiac arrhythmias Cholecystitis Pregnancy Eyelid ptosis	Positive family history	Muscles often contract and are unable to relax	Mutations in the DMPK gene	N/A	N/A	Myopathic
	Glycogen storage disease^[26]	Variable	Proximal	−	−	−	−	−	+	−	−	AR Faituge Hypoglycemia	Exercise intolerance	Hypotonia Hepatomegaly	Lactic acidosis Elevated liver enzymes Ketosis	↑↑	Normal	Normal
Organ system	Disease	Age of onset	Muscle weakness	Fever	Myalgia	Contractures	Gait abnormality	Neuropathy	Atrophy	Stiffness	Myoglobinuria	Other features	History	Physical Examination	Laboratory Findings	Creatine Kinase	Muscle Biopsy	Electromyogram
Infectious	Lyme disease^[27]	Variable	Proximal	+	+	−	+/−	+	−	−	−	Erythema Migrans Flu−like symptoms Lyme arthritis Neurological manifestations	H/o tick bite Hiking trip	Target−like lesions HSM	Clinical diagnosis +Serology	N/A	N/A	N/A
	Influenza^[28]	Variable	Proximal and Distal	+	+	−	+	−	−	−	+	Fever Malaise Rhinorrhea Muscle pain worse with movement	Cold weather H/o Ill contacts	Muscle weakness, tenderness, and swelling.	↑↑ Liver enzymes Positive PCR	↑↑	N/A	N/A
	Polio^[29]	<5 yrs	Proximal	−	−	−	+	+	+	−	−	Asymmetrical paralysis Muscle atrophy Tremors Skeletal deformities	History of skipped immunization.	Normal Meningeal signs Asymmetrical flaccid paralysis Pharyngeal paralysis	Isolation from pharyngealsecretions, CSF Positive serology	N/A	N/A	Neurological pattern
	Syphilis^[30]	Variable	Negative	−	−	−	+	+	−	−	−	Chancre Lymphadenopathy Condylomata lata Neuro syphilis Cardiovascular syphilis	History of risk factors (MSM, unprotected sex, multiple sex partners)	Non−tender chancre in primary syphilis. Followed by rash Generalized lymphadenopathy in secondary syphilis	Darkfield examinations VDRL RPR FTA−ABS	N/A	N/A	N/A
	Pyomyositis^[31]	Variable	Proximal & Distal	+	+	−	−	−	−	+	−	Fever Malaise Psoas abscess	Immunocompromised	Muscles are painful, swollen, tender, and indurated. Depending on the site of involvement, it may mimic appendicitis (psoas muscle), septic arthritis of the hip (iliacus muscle), or epidural abscess (piriformis muscle).	Leukocytosis Elevated ESR	N/A	N/A	N/A
Organ system	Disease	Age of onset	Muscle weakness	Fever	Myalgia	Contractures	Gait abnormality	Neuropathy	Atrophy	Stiffness	Myoglobinuria	Other features	History	Physical Examination	Laboratory Findings	Creatine Kinase	Muscle Biopsy	Electromyogram
Neurologic	ALS^[32]	>35	Proximal & Distal Distal	−	−	−	−	+	+	+	−	Dysphagia Spasticity Hyperreflexia Babinski's +	N/A	Both upper and lower motor neuron signs	Clinical diagnosis	Normal	Nonspecific findings of chronic denervation with reinnervation	Neuropathic
	Stroke^[33]	>65	Proximal & distal	−	−	−	+	+	+	−	−	Dysphagia Unilateral/Bilateral weakness	H/o HTN, dyslipidaemia DM	Weakness of the involved arm	Head CT	Normal	Normal	Neuropathic
	GBS^[34]	18 −350	Proximal	−	−	−	+	−	−	+	−	Ascending paralysis	Precedes a gastrointestinal disease	Weakness of lower extremities followed by upper extremities	Cytologic albumin ratio	Normal	Normal	Neuropathic
	Multiple Sclerosis^[35]	30's	Proximal & distal	−	−	−	+	+	−	−	−	Ocular findings Urinary incontinence Problems with speech or swallowing	Attacks or exacerbation	Localized weakness Focal sensory disturbances Hyper reactive reflexes Increased tone or stiffness	Head CT ologo−clonal bands	Normal	N/A	Neuropathic
Organ system	Disease	Age of onset	Muscle weakness	Fever	Myalgia	Contractures	Gait abnormality	Neuropathy	Atrophy	Stiffness	Myoglobinuria	Other features	History	Physical Examination	Laboratory Findings	Creatine Kinase	Muscle Biopsy	Electromyogram
Neuromuscular	Botulinum^[36]	Variable	Distal	−	−	−	+	−	−	+	−	Double vision Blurred vision Drooping eyelids Slurred speech Difficulty swallowing	H/O food exposure	Hyporeflexia Decreased strength	+Toxin	Normal	N/A	Myopathic
	Lambert−Eaton syndrome^[37]	Variable	Distal	−	−	+	+	−	−	+	−	Weakness of the bulbar muscles Ocular Limb weakness	Weaknessa is often relieved temporarily after exertion or physical exercise.		Antibodies against voltage−gated calcium channels
	Myasthenia gravis^[38]	Variable	Proximal	−	−	+	+	−	−	+	−	Ocular Bulbar Limb weakness Isolated neck, limbs and respiratory weakness	Weakness often worsens with activity		Antibodies that block or destroy nicotinic acetylcholine receptors

References

↑ Pease CT, Haugeberg G, Montague B; et al. (2009). "Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study". Rheumatology (Oxford). 48 (2): 123–7. doi:10.1093/rheumatology/ken343. PMID 18980958. Unknown parameter |month= ignored (help)
↑ Pease CT, Haugeberg G, Morgan AW, Montague B, Hensor EM, Bhakta BB (2005). "Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation". J. Rheumatol. 32 (6): 1043–6. PMID 15940765. Unknown parameter |month= ignored (help)
↑ Sørensen CD, Hansen LH, Hørslev-Petersen K (2010). "[Myositis as differential diagnosis in polymyalgia rheumatica]". Ugeskr. Laeg. (in Danish). 172 (42): 2899–900. PMID 21040663. Unknown parameter |month= ignored (help)
↑ Hopkinson ND, Shawe DJ, Gumpel JM (1991). "Polymyositis, not polymyalgia rheumatica". Ann. Rheum. Dis. 50 (5): 321–2. PMC 1004419. PMID 2042988. Unknown parameter |month= ignored (help)
↑ Manganelli P, Borghi L, Coruzzi P, Novarini A, Ambanelli U (1986). "[Paraneoplastic polymyalgia rheumatica. Case contribution]". Minerva Med. (in Italian). 77 (38): 1739–41. PMID 3774196. Unknown parameter |month= ignored (help)
↑ Kwiatkowska B, Filipowicz-Sosnowska A (2008). "[Polymyalgia rheumatica mimicking neoplastic disease--significant problem in elderly patients]". Pol. Arch. Med. Wewn. (in Polish). 118 Suppl: 47–9. PMID 19562970.
↑ Auzary C, Le Thi Huong D, Delarbre X; et al. (2006). "Subacute bacterial endocarditis presenting as polymyalgia rheumatica or giant cell arteritis". Clin. Exp. Rheumatol. 24 (2 Suppl 41): S38–40. PMID 16859595.
↑ Gupta A, Gupta Y (September 2013). "Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment". Indian J Endocrinol Metab. 17 (5): 913–6. doi:10.4103/2230-8210.117215. PMC 3784879. PMID 24083177.
↑ Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ (2011). "Statin-induced myopathies". Pharmacol Rep. 63 (4): 859–66. PMID 22001973.
↑ Preedy VR, Adachi J, Ueno Y, Ahmed S, Mantle D, Mullatti N, Rajendram R, Peters TJ (November 2001). "Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis". Eur. J. Neurol. 8 (6): 677–87. PMID 11784353.
↑ Sharma V, Borah P, Basumatary LJ, Das M, Goswami M, Kayal AK (July 2014). "Myopathies of endocrine disorders: A prospective clinical and biochemical study". Ann Indian Acad Neurol. 17 (3): 298–302. doi:10.4103/0972-2327.138505. PMC 4162016. PMID 25221399.
↑ Ruff RL, Weissmann J (August 1988). "Endocrine myopathies". Neurol Clin. 6 (3): 575–92. PMID 3065602.
↑ Sambrook MA, Heron JR, Aber GM (April 1972). "Myopathy in association with primary hyperaldosteronism". J. Neurol. Neurosurg. Psychiatry. 35 (2): 202–7. PMC 494037. PMID 5037033.
↑ Li Q, Liu Y, Zhang Q, Tian H, Li J, Li S (July 2017). "Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report". Medicine (Baltimore). 96 (30): e7591. doi:10.1097/MD.0000000000007591. PMC 5627834. PMID 28746208.
↑ Khaleeli AA, Griffith DG, Edwards RH (September 1983). "The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle". Clin. Endocrinol. (Oxf). 19 (3): 365–76. PMID 6627693.
↑ Horton WB, Taylor JS, Ragland TJ, Subauste AR (2015). "Diabetic muscle infarction: a systematic review". BMJ Open Diabetes Res Care. 3 (1): e000082. doi:10.1136/bmjdrc-2015-000082. PMC 4410119. PMID 25932331.
↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
↑ Ohara N, Katada S, Yamada T, Mezaki N, Suzuki H, Suzuki A, Hanyu O, Yoneoka Y, Kawachi I, Shimohata T, Kakita A, Nishizawa M, Sone H (2016). "Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism". Intern. Med. 55 (21): 3185–3190. doi:10.2169/internalmedicine.55.5926. PMC 5140872. PMID 27803417.
↑ Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.
↑ Flanigan KM (August 2014). "Duchenne and Becker muscular dystrophies". Neurol Clin. 32 (3): 671–88, viii. doi:10.1016/j.ncl.2014.05.002. PMID 25037084.
↑ Flanigan KM (August 2014). "Duchenne and Becker muscular dystrophies". Neurol Clin. 32 (3): 671–88, viii. doi:10.1016/j.ncl.2014.05.002. PMID 25037084.
↑ Guglieri M, Straub V, Bushby K, Lochmüller H (October 2008). "Limb-girdle muscular dystrophies". Curr. Opin. Neurol. 21 (5): 576–84. doi:10.1097/WCO.0b013e32830efdc2. PMID 18769252.
↑ Udd B, Krahe R (October 2012). "The myotonic dystrophies: molecular, clinical, and therapeutic challenges". Lancet Neurol. 11 (10): 891–905. doi:10.1016/S1474-4422(12)70204-1. PMID 22995693.
↑ Kannourakis G (April 2002). "Glycogen storage disease". Semin. Hematol. 39 (2): 103–6. PMID 11957192.
↑ Schoenen J, Sianard-Gainko J, Carpentier M, Reznik M (August 1989). "Myositis during Borrelia burgdorferi infection (Lyme disease)". J. Neurol. Neurosurg. Psychiatry. 52 (8): 1002–5. PMC 1031843. PMID 2795056.
↑ Bove KE, Hilton PK, Partin J, Farrell MK (1983). "Morphology of acute myopathy associated with influenza B infection". Pediatr Pathol. 1 (1): 51–66. PMID 6687269.
↑ Howard RS (June 2005). "Poliomyelitis and the postpolio syndrome". BMJ. 330 (7503): 1314–8. doi:10.1136/bmj.330.7503.1314. PMC 558211. PMID 15933355.
↑ French P (January 2007). "Syphilis". BMJ. 334 (7585): 143–7. doi:10.1136/bmj.39085.518148.BE. PMC 1779891. PMID 17235095.
↑ Crum NF (September 2004). "Bacterial pyomyositis in the United States". Am. J. Med. 117 (6): 420–8. doi:10.1016/j.amjmed.2004.03.031. PMID 15380499.
↑ Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015). "A comprehensive review of amyotrophic lateral sclerosis". Surg Neurol Int. 6: 171. doi:10.4103/2152-7806.169561. PMC 4653353. PMID 26629397.
↑ Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S (May 2010). "Acute ischemic stroke update". Pharmacotherapy. 30 (5): 493–514. doi:10.1592/phco.30.5.493. PMID 20412000.
↑ van Doorn PA (June 2013). "Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS)". Presse Med. 42 (6 Pt 2): e193–201. doi:10.1016/j.lpm.2013.02.328. PMID 23628447.
↑ Goldenberg MM (March 2012). "Multiple sclerosis review". P T. 37 (3): 175–84. PMC 3351877. PMID 22605909.
↑ Cherington M (June 2004). "Botulism: update and review". Semin Neurol. 24 (2): 155–63. doi:10.1055/s-2004-830901. PMID 15257512.
↑ Titulaer MJ, Lang B, Verschuuren JJ (December 2011). "Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies". Lancet Neurol. 10 (12): 1098–107. doi:10.1016/S1474-4422(11)70245-9. PMID 22094130.
↑ Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J (2012). "Myasthenia gravis: a review". Autoimmune Dis. 2012: 874680. doi:10.1155/2012/874680. PMC 3501798. PMID 23193443.

Template:WH Template:WS

[pmid18980958-1] Pease CT, Haugeberg G, Montague B; et al. (2009). "Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study". Rheumatology (Oxford). 48 (2): 123–7. doi:10.1093/rheumatology/ken343. PMID 18980958. Unknown parameter |month= ignored (help)

[pmid15940765-2] Pease CT, Haugeberg G, Morgan AW, Montague B, Hensor EM, Bhakta BB (2005). "Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation". J. Rheumatol. 32 (6): 1043–6. PMID 15940765. Unknown parameter |month= ignored (help)

[pmid21040663-3] Sørensen CD, Hansen LH, Hørslev-Petersen K (2010). "[Myositis as differential diagnosis in polymyalgia rheumatica]". Ugeskr. Laeg. (in Danish). 172 (42): 2899–900. PMID 21040663. Unknown parameter |month= ignored (help)

[pmid2042988-4] Hopkinson ND, Shawe DJ, Gumpel JM (1991). "Polymyositis, not polymyalgia rheumatica". Ann. Rheum. Dis. 50 (5): 321–2. PMC 1004419. PMID 2042988. Unknown parameter |month= ignored (help)

[pmid3774196-5] Manganelli P, Borghi L, Coruzzi P, Novarini A, Ambanelli U (1986). "[Paraneoplastic polymyalgia rheumatica. Case contribution]". Minerva Med. (in Italian). 77 (38): 1739–41. PMID 3774196. Unknown parameter |month= ignored (help)

[pmid19562970-6] Kwiatkowska B, Filipowicz-Sosnowska A (2008). "[Polymyalgia rheumatica mimicking neoplastic disease--significant problem in elderly patients]". Pol. Arch. Med. Wewn. (in Polish). 118 Suppl: 47–9. PMID 19562970.

[pmid16859595-7] Auzary C, Le Thi Huong D, Delarbre X; et al. (2006). "Subacute bacterial endocarditis presenting as polymyalgia rheumatica or giant cell arteritis". Clin. Exp. Rheumatol. 24 (2 Suppl 41): S38–40. PMID 16859595.

[pmid24083177-8] Gupta A, Gupta Y (September 2013). "Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment". Indian J Endocrinol Metab. 17 (5): 913–6. doi:10.4103/2230-8210.117215. PMC 3784879. PMID 24083177.

[pmid22001973-9] Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ (2011). "Statin-induced myopathies". Pharmacol Rep. 63 (4): 859–66. PMID 22001973.

[pmid11784353-10] Preedy VR, Adachi J, Ueno Y, Ahmed S, Mantle D, Mullatti N, Rajendram R, Peters TJ (November 2001). "Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis". Eur. J. Neurol. 8 (6): 677–87. PMID 11784353.

[pmid25221399-11] Sharma V, Borah P, Basumatary LJ, Das M, Goswami M, Kayal AK (July 2014). "Myopathies of endocrine disorders: A prospective clinical and biochemical study". Ann Indian Acad Neurol. 17 (3): 298–302. doi:10.4103/0972-2327.138505. PMC 4162016. PMID 25221399.

[pmid30656022-12] Ruff RL, Weissmann J (August 1988). "Endocrine myopathies". Neurol Clin. 6 (3): 575–92. PMID 3065602.

[pmid5037033-13] Sambrook MA, Heron JR, Aber GM (April 1972). "Myopathy in association with primary hyperaldosteronism". J. Neurol. Neurosurg. Psychiatry. 35 (2): 202–7. PMC 494037. PMID 5037033.

[pmid28746208-14] Li Q, Liu Y, Zhang Q, Tian H, Li J, Li S (July 2017). "Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report". Medicine (Baltimore). 96 (30): e7591. doi:10.1097/MD.0000000000007591. PMC 5627834. PMID 28746208.

[pmid6627693-15] Khaleeli AA, Griffith DG, Edwards RH (September 1983). "The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle". Clin. Endocrinol. (Oxf). 19 (3): 365–76. PMID 6627693.

[pmid25932331-16] Horton WB, Taylor JS, Ragland TJ, Subauste AR (2015). "Diabetic muscle infarction: a systematic review". BMJ Open Diabetes Res Care. 3 (1): e000082. doi:10.1136/bmjdrc-2015-000082. PMC 4410119. PMID 25932331.

[pmid1658649-17] Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.

[pmid16586492-18] Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.

[pmid16586493-19] Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.

[pmid27803417-20] Ohara N, Katada S, Yamada T, Mezaki N, Suzuki H, Suzuki A, Hanyu O, Yoneoka Y, Kawachi I, Shimohata T, Kakita A, Nishizawa M, Sone H (2016). "Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism". Intern. Med. 55 (21): 3185–3190. doi:10.2169/internalmedicine.55.5926. PMC 5140872. PMID 27803417.

[pmid8948307-21] Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.

[pmid25037084-22] Flanigan KM (August 2014). "Duchenne and Becker muscular dystrophies". Neurol Clin. 32 (3): 671–88, viii. doi:10.1016/j.ncl.2014.05.002. PMID 25037084.

[pmid250370842-23] Flanigan KM (August 2014). "Duchenne and Becker muscular dystrophies". Neurol Clin. 32 (3): 671–88, viii. doi:10.1016/j.ncl.2014.05.002. PMID 25037084.

[pmid18769252-24] Guglieri M, Straub V, Bushby K, Lochmüller H (October 2008). "Limb-girdle muscular dystrophies". Curr. Opin. Neurol. 21 (5): 576–84. doi:10.1097/WCO.0b013e32830efdc2. PMID 18769252.

[pmid22995693-25] Udd B, Krahe R (October 2012). "The myotonic dystrophies: molecular, clinical, and therapeutic challenges". Lancet Neurol. 11 (10): 891–905. doi:10.1016/S1474-4422(12)70204-1. PMID 22995693.

[pmid11957192-26] Kannourakis G (April 2002). "Glycogen storage disease". Semin. Hematol. 39 (2): 103–6. PMID 11957192.

[pmid2795056-27] Schoenen J, Sianard-Gainko J, Carpentier M, Reznik M (August 1989). "Myositis during Borrelia burgdorferi infection (Lyme disease)". J. Neurol. Neurosurg. Psychiatry. 52 (8): 1002–5. PMC 1031843. PMID 2795056.

[pmid6687269-28] Bove KE, Hilton PK, Partin J, Farrell MK (1983). "Morphology of acute myopathy associated with influenza B infection". Pediatr Pathol. 1 (1): 51–66. PMID 6687269.

[pmid15933355-29] Howard RS (June 2005). "Poliomyelitis and the postpolio syndrome". BMJ. 330 (7503): 1314–8. doi:10.1136/bmj.330.7503.1314. PMC 558211. PMID 15933355.

[pmid17235095-30] French P (January 2007). "Syphilis". BMJ. 334 (7585): 143–7. doi:10.1136/bmj.39085.518148.BE. PMC 1779891. PMID 17235095.

[pmid15380499-31] Crum NF (September 2004). "Bacterial pyomyositis in the United States". Am. J. Med. 117 (6): 420–8. doi:10.1016/j.amjmed.2004.03.031. PMID 15380499.

[pmid26629397-32] Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015). "A comprehensive review of amyotrophic lateral sclerosis". Surg Neurol Int. 6: 171. doi:10.4103/2152-7806.169561. PMC 4653353. PMID 26629397.

[pmid20412000-33] Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S (May 2010). "Acute ischemic stroke update". Pharmacotherapy. 30 (5): 493–514. doi:10.1592/phco.30.5.493. PMID 20412000.

[pmid23628447-34] van Doorn PA (June 2013). "Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS)". Presse Med. 42 (6 Pt 2): e193–201. doi:10.1016/j.lpm.2013.02.328. PMID 23628447.

[pmid22605909-35] Goldenberg MM (March 2012). "Multiple sclerosis review". P T. 37 (3): 175–84. PMC 3351877. PMID 22605909.

[pmid15257512-36] Cherington M (June 2004). "Botulism: update and review". Semin Neurol. 24 (2): 155–63. doi:10.1055/s-2004-830901. PMID 15257512.

[pmid22094130-37] Titulaer MJ, Lang B, Verschuuren JJ (December 2011). "Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies". Lancet Neurol. 10 (12): 1098–107. doi:10.1016/S1474-4422(11)70245-9. PMID 22094130.

[pmid23193443-38] Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J (2012). "Myasthenia gravis: a review". Autoimmune Dis. 2012: 874680. doi:10.1155/2012/874680. PMC 3501798. PMID 23193443.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

[35]

[36]

[37]

[38]

@@ Line 123: / Line 123: @@
-{| class="wikitable"
+{|
-! rowspan="3" |Disease
+! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system
-! colspan="9" |Symptoms
+! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
-! rowspan="3" |History
+! colspan="12" style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptoms
-! rowspan="3" |Physical
+! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |History
+! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Physical
 Examination
-! colspan="4" |Diagnosis
+! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
 |-
-! rowspan="2" |Age of onset
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Age of onset
-! colspan="2" |Muscle weakness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle weakness
-! rowspan="2" |Fever
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
-! rowspan="2" |Muscle pain
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myalgia
-! rowspan="2" |Gait abnormality
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Contractures'''
-! rowspan="2" |Neuropathy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gait abnormality
-! rowspan="2" |Myoglobinuria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuropathy
-! rowspan="2" |Other features
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Atrophy
-! rowspan="2" |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stiffness
-! rowspan="2" |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myoglobinuria
-! rowspan="2" |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
-! rowspan="2" |Electromyogram
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram
 |-
-!Proximal
+! rowspan="3" style="background:#DCDCDC;" align="center" + |Medication−induced
-!DIstal
+! style="background:#DCDCDC;" align="center" + |[[Corticosteroids]]<ref name="pmid24083177">{{cite journal |vauthors=Gupta A, Gupta Y |title=Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment |journal=Indian J Endocrinol Metab |volume=17 |issue=5 |pages=913–6 |date=September 2013 |pmid=24083177 |pmc=3784879 |doi=10.4103/2230-8210.117215 |url=}}</ref>
-|-
+| style="background:#F5F5F5;" align="center" + |Variable
-! colspan="16" |Medications
+| style="background:#F5F5F5;" align="center" + |Proximal
-|-
+| style="background:#F5F5F5;" align="center" + |−
-|Corticosteroids
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + | −
-* Variable
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="left" + |
-| -
+* [[Central obesity]]
-|<nowiki>-</nowiki>
-|
-* Central obesity
 * Excessive [[sweating]]
 * [[Insomnia]]
@@ Line 167: / Line 168: @@
 * [[Infertility]]
 * Psychological disturbances
-|
+| style="background:#F5F5F5;" align="left" + |
-*+  History of medications
+*Positive h/o medications
-|
+| style="background:#F5F5F5;" align="left" + |
-* Facial and sphincter muscles usually are spared
+* Facial and sphincter [[Muscle|muscles]] are usually spared
-|
+| style="background:#F5F5F5;" align="left" + |
-* + ACTH Stimulation test
+* Positive [[ACTH stimulation test]]
 * 24-hour urine [[cortisol]]
-* Low dose [[dexamethasone]] suppression test
+* Low dose [[dexamethasone suppression test]]
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="left" + |
-|<nowiki>-</nowiki>
+* Normal
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="left" + |
+* Normal
+| style="background:#F5F5F5;" align="left" + |
+* Normal
 |-
-|Statins
+! style="background:#DCDCDC;" align="center" + |[[Statins]]<ref name="pmid22001973">{{cite journal |vauthors=Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ |title=Statin-induced myopathies |journal=Pharmacol Rep |volume=63 |issue=4 |pages=859–66 |date=2011 |pmid=22001973 |doi= |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |60+
-* 60+
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-| -
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-/+(rhabdomyolysis)</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−/+([[Rhabdomyolysis]])
+| style="background:#F5F5F5;" align="left" + |
 * N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* Positive medication history
+*Positive h/o medications
-|
+*H/o other medication use
-* Tenderness
+| style="background:#F5F5F5;" align="left" + |
+* [[Tenderness]]
 * Muscle aches
-|
+| style="background:#F5F5F5;" align="left" + |
-* '''↑↑''' liver enzymes
+* '''↑↑''' Liver enzymes
-|
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
-* Necrosis
+* [[Necrosis]]
 * Degeneration, and regeneration of fibers
 * Phagocytic infiltration
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="left" + |
+* Normal
 |-
-|Alcohol
+! style="background:#DCDCDC;" align="center" + |[[Alcohol]]<ref name="pmid11784353">{{cite journal |vauthors=Preedy VR, Adachi J, Ueno Y, Ahmed S, Mantle D, Mullatti N, Rajendram R, Peters TJ |title=Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis |journal=Eur. J. Neurol. |volume=8 |issue=6 |pages=677–87 |date=November 2001 |pmid=11784353 |doi= |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |Variable
-* Variable
+| style="background:#F5F5F5;" align="center" + |Proximal
-|      '''+'''
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | +/−
-|<nowiki>+/-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-* Swelling
+| style="background:#F5F5F5;" align="left" + |
+* [[Swelling]]
 * Tender
-* Erythema and induration
+* [[Erythema]] and induration
-|
+| style="background:#F5F5F5;" align="left" + |
-* Alcohol intoxication
+* [[Alcohol]] intoxication
-|
+| style="background:#F5F5F5;" align="left" + |
-* Change in mental status
+* Change in [[mental status]]
-* Telangiectasia
+* [[Telangiectasias|Telangiectasia]]
-* Peripheral neuropathy
+* [[Peripheral neuropathy]]
-|
+| style="background:#F5F5F5;" align="left" + |
-*  nonspecific and are normal in many patients
+* Monspecific and are normal in many patients
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal or '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 |-
-! colspan="16" |Endocrine
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Age of onset
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle weakness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myalgia
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Contractures'''
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gait abnormality
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuropathy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Atrophy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stiffness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myoglobinuria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |History
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Physical
+Examination
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram
 |-
-|Cushing's disease
+! rowspan="6" style="background:#DCDCDC;" align="center" + |Endocrine
-|
+! style="background:#DCDCDC;" align="center" + |[[Cushing's disease]]<ref name="pmid25221399">{{cite journal |vauthors=Sharma V, Borah P, Basumatary LJ, Das M, Goswami M, Kayal AK |title=Myopathies of endocrine disorders: A prospective clinical and biochemical study |journal=Ann Indian Acad Neurol |volume=17 |issue=3 |pages=298–302 |date=July 2014 |pmid=25221399 |pmc=4162016 |doi=10.4103/0972-2327.138505 |url=}}</ref>
-* 25 -45
+| style="background:#F5F5F5;" align="center" + |25 −45
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
-* Decreased libido
+| style="background:#F5F5F5;" align="center" + |−
-* Obesity/weight gain
+| style="background:#F5F5F5;" align="left" + |
-* Plethora
+* [[Decreased libido]]
+* [[Obesity]]/[[weight gain]]
+* [[Plethora]]
 * Round face
 * Menstrual changes
-* Hirsutism
+* [[Hirsutism]]
-* Hypertension
+* [[Hypertension]]
-* Ecchymoses
+* [[Ecchymoses]]
-* Lethargy, depression
+* [[Lethargy]]
+* [[Depression]]
 * Dorsal fat pad
 * Abnormal glucose tolerance
-|
+| style="background:#F5F5F5;" align="left" + |
 * N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* Facial and sphincter muscles usually are spared
+* Facial and sphincter [[muscles]] are usually spared
-* Overweight
+* [[Overweight]]
 * Straie
-* Moon face
+* [[Moon face]]
-* HTN
+* [[Hypertension|HTN]]
-* Hyperpigmentation
+* [[Hyperpigmentation]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* + ACTH Stimulation test
+* Positive [[ACTH stimulation test]]
 * 24-hour urine [[cortisol]]
-* Low dose [[dexamethasone]] suppression test
+* Low dose [[Dexamethasone suppression test|dexamethasone <nowiki/>suppression test]]
-|Normal
+| style="background:#F5F5F5;" align="left" + |
-|
+* Normal
+| style="background:#F5F5F5;" align="left" + |
 * Atrophy of type 2 muscle fibers, especially type 2B
-|Normal
+| style="background:#F5F5F5;" align="left" + |Normal
 |-
-|Adrenal insufficiency
+! style="background:#DCDCDC;" align="center" + |[[Adrenal insufficiency]]<ref name="pmid30656022">{{cite journal |vauthors=Ruff RL, Weissmann J |title=Endocrine myopathies |journal=Neurol Clin |volume=6 |issue=3 |pages=575–92 |date=August 1988 |pmid=3065602 |doi= |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |30−50 years
-* 30-50 years
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
-* Signs of glucocorticoid, mineralocorticoid, and, androgen deficiency.
+| style="background:#F5F5F5;" align="left" + |
-|
+* Signs of [[glucocorticoid]], [[mineralocorticoid]], and, [[androgen]] deficiency
+| style="background:#F5F5F5;" align="left" + |
 * Signs of [[postural hypotension]]
 * History of [[tuberculosis]]
 * History of [[malignancy]]
 * History of other [[autoimmune disease]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Hypotension
+* [[Hypotension]]
+* [[Hyperpigmentation]]
-* Hyperpigmentation
+* Auricular−cartilage calcification
+* [[Vitiligo]]
-* Auricular-cartilage calcification
+| style="background:#F5F5F5;" align="left" + |
+* [[Electrolyte abnormalities]]
-* Vitiligo
+* [[Hypoglycemia]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Electrolyte abnormalities
-* Hypoglycemia
-|
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 |-
-|Hyperaldosteronism with myopathy
+! style="background:#DCDCDC;" align="center" + |[[Hyperaldosteronism]] with myopathy<ref name="pmid5037033">{{cite journal |vauthors=Sambrook MA, Heron JR, Aber GM |title=Myopathy in association with primary hyperaldosteronism |journal=J. Neurol. Neurosurg. Psychiatry |volume=35 |issue=2 |pages=202–7 |date=April 1972 |pmid=5037033 |pmc=494037 |doi= |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |50
-* 50
+| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>distal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-Rhabdomyolysis
+[[Rhabdomyolysis]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Palpitations
+* [[Palpitations]]
-* Hypertension
+* [[Hypertension]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Episodes of heart beats
+* Episodes of [[Palpation|increased heart beats]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Hyperpigmentation
+* [[Hyperpigmentation]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Hypokalemia
+* [[Hypokalemia]]
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 |-
-|Hyperthyroidism
+! style="background:#DCDCDC;" align="center" + |[[Hyperthyroidism]]<ref name="pmid28746208">{{cite journal |vauthors=Li Q, Liu Y, Zhang Q, Tian H, Li J, Li S |title=Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report |journal=Medicine (Baltimore) |volume=96 |issue=30 |pages=e7591 |date=July 2017 |pmid=28746208 |pmc=5627834 |doi=10.1097/MD.0000000000007591 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |40
-* 40
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-* Signs of hyperthyroidism
+| style="background:#F5F5F5;" align="left" + |
-|
+* Signs of [[hyperthyroidism]]
-* Sweating
+| style="background:#F5F5F5;" align="left" + |
-* Tremor'
+* H/o of [[weight loss]]
-* H/o of weight loss
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Sweating]]
-* Sweating
+* [[Tremor]]
-* Tremor'
+* Neck swelling
-* Swelling on neck examination
+| style="background:#F5F5F5;" align="left" + |
-|
+* Decreased [[TSH]]
-* Decreased TSH
+| style="background:#F5F5F5;" align="left" + |
-|
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
 * Non specific
-|
+| style="background:#F5F5F5;" align="left" + |
-* Myotonic
+* [[Myotonic]]
 |-
-|Hypothyroidism
+! style="background:#DCDCDC;" align="center" + |[[Hypothyroidism]]<ref name="pmid6627693">{{cite journal |vauthors=Khaleeli AA, Griffith DG, Edwards RH |title=The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle |journal=Clin. Endocrinol. (Oxf) |volume=19 |issue=3 |pages=365–76 |date=September 1983 |pmid=6627693 |doi= |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |55
-* >55
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-| -
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+ Rhabdomyolysis</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-|
+| style="background:#F5F5F5;" align="center" + | + [[Rhabdomyolysis MRI|Rhabdomyolysis]]
-*  Signs of hypothyroidism
+| style="background:#F5F5F5;" align="left" + |
-|
+*  Signs of [[hypothyroidism]]
-* H/o weight gain
+| style="background:#F5F5F5;" align="left" + |
-|
+* H/o [[weight gain]]
-* Myoedema
+| style="background:#F5F5F5;" align="left" + |
+* [[Myxedema|Myxoedema]]
 * Muscle pseudohypertrophy
-|
+| style="background:#F5F5F5;" align="left" + |
-* Increased TSH
+* Increased [[TSH]]
-|
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
 * Nonspecific
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 |-
-|Diabetic infraction
+! style="background:#DCDCDC;" align="center" + |Diabetic infraction<ref name="pmid25932331">{{cite journal |vauthors=Horton WB, Taylor JS, Ragland TJ, Subauste AR |title=Diabetic muscle infarction: a systematic review |journal=BMJ Open Diabetes Res Care |volume=3 |issue=1 |pages=e000082 |date=2015 |pmid=25932331 |pmc=4410119 |doi=10.1136/bmjdrc-2015-000082 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |45
-* 45
+| style="background:#F5F5F5;" align="center" + |Proximal
-| +
+| style="background:#F5F5F5;" align="center" + | +
-| -
+| style="background:#F5F5F5;" align="center" + | +
-| +
+| style="background:#F5F5F5;" align="center" + |−
-| +
+| style="background:#F5F5F5;" align="center" + |−
-| -
+| style="background:#F5F5F5;" align="center" + | +
-| +
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-| -
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | −
-* Cramps
+| style="background:#F5F5F5;" align="left" + |
-* Sudden onset of pain
+* [[Cramps]]
-* Anterior thigh muscles are most commonly involved
+* Sudden onset of [[pain]]
-*
+* Anterior thigh [[muscles]] are most commonly involved
-|
+| style="background:#F5F5F5;" align="left" + |
-* H/O long standing diabetes
+* H/O long standing [[diabetes]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Swelling
+* [[Swelling]]
+* [[Tenderness]]
-* Tenderness
+| style="background:#F5F5F5;" align="left" + |
-|
+* Elevated [[ESR]]
-* Elevation of the erythrocyte sedimentation rate
+* [[Leukocytosis]]
-* Leukocytosis
+| style="background:#F5F5F5;" align="left" + |
-|
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
-* Necrosis
+* [[Necrosis]]
-* Edema
+* [[Edema]]
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 |-
-! colspan="16" |Inflammatory / Rheumatologic
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Age of onset
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle weakness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myalgia
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Contractures'''
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gait abnormality
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuropathy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Atrophy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stiffness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myoglobinuria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |History
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Physical
+Examination
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram
 |-
-|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
+! rowspan="5" style="background:#DCDCDC;" align="center" + |Inflammatory/ Rheumatologic
-|
+! style="background:#DCDCDC;" align="center" + |[[Dermatomyositis]]<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
-* 40s-50s
+| style="background:#F5F5F5;" align="center" + |40s−50s<br>Can affect children
-* Can affect childreen
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-| -
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-| +
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + |−
-| -
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + | −
-* Rash
+| style="background:#F5F5F5;" align="left" + |
-* Dyspnea
+* [[Rash]]
-* Weight loss
+* [[Dyspnea]]
-* Cough
+* [[Weight loss]]
-|
+* [[Cough]]
-|
+| style="background:#F5F5F5;" align="left" + |
+* [[Viral infections]]
+* [[Cancer]]
+| style="background:#F5F5F5;" align="left" + |
 * Heliotrope rash on face and hands
-* Telangectasia
+* [[Telangiectasia]]
-* Erythema
+* [[Erythema]]
 * Mechanic's hands
-* Gottron's sign ( violaceous scaly eruption )
+* [[Gottron's papules|Gottron's sign]] ( violaceous scaly eruption )
-| rowspan="2" |
+| style="background:#F5F5F5;" align="left" + |
-* '''↑↑''' ESR
+* '''↑↑''' [[Erythrocyte sedimentation rate|ESR]]
-* '''↑↑''' CRP
+* '''↑↑''' [[C-reactive protein|CRP]]
-|
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
 * Perimysial mononuclear infiltrate
-| rowspan="2" |
+| rowspan="2" style="background:#F5F5F5;" align="left" + |
-* Muscle inflammation and damage
+* [[Myopathic]]
 |-
-|Polymyositis<ref name="pmid16586492">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
+! style="background:#DCDCDC;" align="center" + |[[Polymyositis]]<ref name="pmid16586492">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |> 18 years
-* > 18 years
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-| -
+| style="background:#F5F5F5;" align="center" + | +
-| +
+| style="background:#F5F5F5;" align="center" + | −
-| +
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + |−
-| -
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + | −
-* Similar to dermatomyositis without mucous and skin involvement
+| style="background:#F5F5F5;" align="left" + |
-|
+* Similar to [[dermatomyositis]] without [[mucous]] and [[skin]] involvement
+| style="background:#F5F5F5;" align="left" + |
 * N/A
-|
+| style="background:#F5F5F5;" align="left" + |
 * N/A
-|
+| style="background:#F5F5F5;" align="left" + |
+* '''↑↑''' [[Erythrocyte sedimentation rate|ESR]]
+* '''↑↑''' [[C-reactive protein|CRP]]
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
 * Endomysial mononuclear infiltrate
 * Patchy necrosis
 |-
-|Inclusion body myositis<ref name="pmid16586493">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
+! style="background:#DCDCDC;" align="center" + |Inclusion body [[myositis]]<ref name="pmid16586493">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |50s
-* 50s
+| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>distal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-| +
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Dysphagia]]
-|
+* Asymmetric weakness
-|
+| style="background:#F5F5F5;" align="left" + |
+* [[Retrovirus]] (most common)
+| style="background:#F5F5F5;" align="left" + |
+* N/A
+| style="background:#F5F5F5;" align="left" + |
+* Antibodies to cytoplasmic 5'−nucleotidase
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Inflammatory cells]]
+* Invading [[muscle cells]]
+* Vacuolar degeneration
+* Inclusions or plaques
+| style="background:#F5F5F5;" align="left" + |
+* [[Neurogenic]]
 |-
-|Fibomyalgia
+! style="background:#DCDCDC;" align="center" + |[[Fibromyalgia]]<ref name="pmid27803417">{{cite journal |vauthors=Ohara N, Katada S, Yamada T, Mezaki N, Suzuki H, Suzuki A, Hanyu O, Yoneoka Y, Kawachi I, Shimohata T, Kakita A, Nishizawa M, Sone H |title=Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism |journal=Intern. Med. |volume=55 |issue=21 |pages=3185–3190 |date=2016 |pmid=27803417 |pmc=5140872 |doi=10.2169/internalmedicine.55.5926 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |40−50s
-* 40-50s
+| style="background:#F5F5F5;" align="center" + |Generalized
-|
+| style="background:#F5F5F5;" align="center" + |−
-+
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + | +
-| -
+| style="background:#F5F5F5;" align="center" + |−
-| ++
+| style="background:#F5F5F5;" align="center" + |−
-| -
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="left" + |
-* Anxiety or depression features
+* [[Anxiety]] or depression features
-* Fatigue
+* [[Fatigue]]
 * Sleep disturbance
-* Numbness
+* [[Numbness]]
-* Muscle spasms
+* [[Muscle spasms]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* History of depressive disorder
+* History of [[depression]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* Tenderness in the soft tissue anatomical location
+* [[Tenderness]] in the soft tissue anatomical location
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 |-
-|Polymyalgia Rheumatica<ref name="pmid8948307">{{cite journal| author=Myklebust G, Gran JT| title=A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. | journal=Br J Rheumatol | year= 1996 | volume= 35 | issue= 11 | pages= 1161-8 | pmid=8948307 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8948307  }}</ref>
+! style="background:#DCDCDC;" align="center" + |[[Polymyalgia rheumatica|Polymyalgia Rheumatica]]<ref name="pmid8948307">{{cite journal| author=Myklebust G, Gran JT| title=A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. | journal=Br J Rheumatol | year= 1996 | volume= 35 | issue= 11 | pages= 1161-8 | pmid=8948307 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8948307  }}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |50s
-* 50s
+| style="background:#F5F5F5;" align="center" + |Diffuse
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-| +
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + |−
-| -
+| style="background:#F5F5F5;" align="center" + | +
-|
+| style="background:#F5F5F5;" align="center" + | −
-* Weight loss
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Weight loss]]
-* History of joints stiffness which is worse in the morning
+| style="background:#F5F5F5;" align="left" + |
-|
+* History of joints stiffness, worse in the morning
+| style="background:#F5F5F5;" align="left" + |
 * Restricted shoulder motion
-|
+| style="background:#F5F5F5;" align="left" + |
-* '''↑ CRP'''
+* '''↑↑''' [[Erythrocyte sedimentation rate|ESR]]
-* '''↑ ESR'''
+* '''↑↑''' [[C-reactive protein|CRP]]
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 |-
-! colspan="16" |Genetic
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Age of onset
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle weakness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myalgia
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Contractures'''
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gait abnormality
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuropathy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Atrophy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stiffness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myoglobinuria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |History
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Physical
+Examination
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram
 |-
-|Becker muscular dystrophy
+! rowspan="5" style="background:#DCDCDC;" align="center" + |Genetic
-|<13yrs
+! style="background:#DCDCDC;" align="center" + |[[Becker's muscular dystrophy|Becker muscular dystrophy]]<ref name="pmid25037084">{{cite journal |vauthors=Flanigan KM |title=Duchenne and Becker muscular dystrophies |journal=Neurol Clin |volume=32 |issue=3 |pages=671–88, viii |date=August 2014 |pmid=25037084 |doi=10.1016/j.ncl.2014.05.002 |url=}}</ref>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<13yrs
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-* Milder form of Duchenne
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-* Growth delay
+| style="background:#F5F5F5;" align="left" + |
-* Age of onset of symptoms is much delayed than duchenne
+* Milder form of [[Duchenne muscular dystrophy|Duchenne]]
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Growth delay]]
+* Age of onset of symptoms is much delayed than [[Duchenne muscular dystrophy|duchenne]]
+| style="background:#F5F5F5;" align="left" + |
+* Positive Grower sign
+| style="background:#F5F5F5;" align="left" + |
 * Decreased amount of [[dystrophin]].
-|
+| style="background:#F5F5F5;" align="left" + |
 * ↑↑
-| rowspan="2" |
+| rowspan="2" style="background:#F5F5F5;" align="left" + |
 ** Muscle fibril degeneration, regeneration
 ** Isolated fiber hypertrophy
 ** Muscle replacement with fat and connective tissue
-| rowspan="2" |
+| rowspan="2" style="background:#F5F5F5;" align="left" + |
-* Myopathic changes
+* [[Myopathic]]
 |-
-|Duchenne muscular dystrophy
+! style="background:#DCDCDC;" align="center" + |[[Duchenne muscular dystrophy]]<ref name="pmid250370842">{{cite journal |vauthors=Flanigan KM |title=Duchenne and Becker muscular dystrophies |journal=Neurol Clin |volume=32 |issue=3 |pages=671–88, viii |date=August 2014 |pmid=25037084 |doi=10.1016/j.ncl.2014.05.002 |url=}}</ref>
-|<13 yrs
+| style="background:#F5F5F5;" align="center" + |<13 yrs
-| +
+| style="background:#F5F5F5;" align="center" + | Proximal
-| -
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-| -
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + | −
+| style="background:#F5F5F5;" align="left" + |
 * Calf psedohypertrophy
+* [[Cardiomyopathy]]
-* Cardiomyopathy
+* [[Kyphoscoliosis]]
+* [[Cognitive impairment]]
-* Kyphoscoliosis
+| style="background:#F5F5F5;" align="left" + |
-* Cognitive impairment
-|
 * Early onset
-*
+| style="background:#F5F5F5;" align="left" + |
-|
+* Positive Grower sign
-* +Grower sign
+| style="background:#F5F5F5;" align="left" + |
-|
 * Errors in the Xp21 gene.
 * Absence of [[dystrophin]].
-|
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑'''
 |-
-|Limb-girdle muscular dystrophies
+! style="background:#DCDCDC;" align="center" + |[[Limb-girdle muscular dystrophy|Limb−girdle muscular]] dystrophies<ref name="pmid18769252">{{cite journal |vauthors=Guglieri M, Straub V, Bushby K, Lochmüller H |title=Limb-girdle muscular dystrophies |journal=Curr. Opin. Neurol. |volume=21 |issue=5 |pages=576–84 |date=October 2008 |pmid=18769252 |doi=10.1097/WCO.0b013e32830efdc2 |url=}}</ref>
-|<15 yrs
+| style="background:#F5F5F5;" align="center" + |<15 yrs
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="left" + |
 * Calf hypertrophy
 * Scapular winging
-* Cardiomyopathy
+* [[Cardiomyopathy]]
-* Cardiac arrhythmias
+* [[Cardiac arrhythmia|Cardiac arrhythmias]]
 * Respiratory muscle weakness
-|
+| style="background:#F5F5F5;" align="left" + |
-* Autosomal dominant
+* [[Autosomal dominant]]
-|
+* Deterioration of ability to run/walk
-*
+| style="background:#F5F5F5;" align="left" + |
-|
+*[[Muscle weakness]] is generally symmetric
-* LMNA gene
+| style="background:#F5F5F5;" align="left" + |
+* [[LMNA]] gene
 * CAV3 gene
-*
+| style="background:#F5F5F5;" align="left" + |
-|
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
+* [[Myopathic]]
 |-
-|Myotonic dystrophy type 1
+| style="background:#DCDCDC;" align="center" + |[[Myotonic dystrophy]]<ref name="pmid22995693">{{cite journal |vauthors=Udd B, Krahe R |title=The myotonic dystrophies: molecular, clinical, and therapeutic challenges |journal=Lancet Neurol |volume=11 |issue=10 |pages=891–905 |date=October 2012 |pmid=22995693 |doi=10.1016/S1474-4422(12)70204-1 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |<18 years
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>distal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | +
-* Myotonia
+| style="background:#F5F5F5;" align="center" + |−
-* Cataracts
+| style="background:#F5F5F5;" align="left" + |
-* Diabetes mellitus
+* [[Myotonia]]
+* [[Cataracts]]
+* [[Diabetes mellitus]]
 * Frontal balding
 * Cardiac arrhythmias
-* Cholecystitis
+* [[Cholecystitis]]
-* Pregnancy
+* [[Pregnancy]]
-* Eyelid ptosis
+* Eyelid [[ptosis]]
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* Positive family history
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* Muscles often contract and are unable to relax
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* Mutations in the [[DMPK]] gene
+| style="background:#F5F5F5;" align="left" + |
+* N/A
+| style="background:#F5F5F5;" align="left" + |
+* N/A
+| style="background:#F5F5F5;" align="left" + |
+* [[Myopathic]]
+|-
+| style="background:#DCDCDC;" align="center" + |[[Glycogen storage disease]]<ref name="pmid11957192">{{cite journal |vauthors=Kannourakis G |title=Glycogen storage disease |journal=Semin. Hematol. |volume=39 |issue=2 |pages=103–6 |date=April 2002 |pmid=11957192 |doi= |url=}}</ref>
+| style="background:#F5F5F5;" align="center" + |Variable
+| style="background:#F5F5F5;" align="center" + |Proximal
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + | −
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="left" + |
+* [[Autosomal recessive|AR]]
+* [[Fatigue|Faituge]]
+* [[Hypoglycemia]]
+| style="background:#F5F5F5;" align="left" + |
+* [[Exercise intolerance]]
+| style="background:#F5F5F5;" align="left" + |
+* [[Hypotonia]]
+* [[Hepatomegaly]]
+| style="background:#F5F5F5;" align="left" + |
+* [[Lactic acidosis]]
+* Elevated liver enzymes
+* [[Ketosis]]
+| style="background:#F5F5F5;" align="left" + |
+* '''↑↑'''
+| style="background:#F5F5F5;" align="left" + |
+* Normal
+| style="background:#F5F5F5;" align="left" + |
+* Normal
 |-
-! colspan="16" |Infectious
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Age of onset
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle weakness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myalgia
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Contractures'''
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gait abnormality
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuropathy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Atrophy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stiffness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myoglobinuria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |History
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Physical
+Examination
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram
 |-
-|Lyme disease
+! rowspan="5" style="background:#DCDCDC;" align="center" + |Infectious
-|Variable
+! style="background:#DCDCDC;" align="center" + |[[Lyme disease]]<ref name="pmid2795056">{{cite journal |vauthors=Schoenen J, Sianard-Gainko J, Carpentier M, Reznik M |title=Myositis during Borrelia burgdorferi infection (Lyme disease) |journal=J. Neurol. Neurosurg. Psychiatry |volume=52 |issue=8 |pages=1002–5 |date=August 1989 |pmid=2795056 |pmc=1031843 |doi= |url=}}</ref>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Variable
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal
-| +
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-| +/-
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | +/−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + | −
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="left" + |
 * Erythema Migrans
-* Flu-like symptoms
+* Flu−like symptoms
 * [[Lyme arthritis]]
 * [[Neurological]] manifestations
-|
+| style="background:#F5F5F5;" align="left" + |
-* + Tick bite
+* H/o tick bite
-* Hiking/Tip
+* Hiking trip
-|
+| style="background:#F5F5F5;" align="left" + |
-* Target-like [[lesions]]
+* Target−like [[lesions]]
 * HSM
-|
+| style="background:#F5F5F5;" align="left" + |
 * Clinical diagnosis
 * +Serology
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
 |-
-|Infulenza
+! style="background:#DCDCDC;" align="center" + |[[Influenza]]<ref name="pmid6687269">{{cite journal |vauthors=Bove KE, Hilton PK, Partin J, Farrell MK |title=Morphology of acute myopathy associated with influenza B infection |journal=Pediatr Pathol |volume=1 |issue=1 |pages=51–66 |date=1983 |pmid=6687269 |doi= |url=}}</ref>
-|Variable
+| style="background:#F5F5F5;" align="center" + |Variable
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | Proximal and Distal
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | +
-| +
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-| +
+| style="background:#F5F5F5;" align="center" + | +
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-* Fever
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-* Malaise
+| style="background:#F5F5F5;" align="left" + |
-* Rhinorrhea
+* [[Fever]]
-* Muscle pain worse with movement
+* [[Malaise]]
-|
+* [[Rhinorrhea]]
-*
+* [[Muscle pain]] worse with movement
-|
+| style="background:#F5F5F5;" align="left" + |
+*Cold weather
+*H/o Ill contacts
+| style="background:#F5F5F5;" align="left" + |
 * Muscle weakness, tenderness, and swelling.
-|
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑''' Liver enzymes
-* +PCR
+* Positive PCR
-|
+| style="background:#F5F5F5;" align="left" + |
 * '''↑↑'''
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
 |-
-|Polio
+! style="background:#DCDCDC;" align="center" + |[[Polio]]<ref name="pmid15933355">{{cite journal |vauthors=Howard RS |title=Poliomyelitis and the postpolio syndrome |journal=BMJ |volume=330 |issue=7503 |pages=1314–8 |date=June 2005 |pmid=15933355 |pmc=558211 |doi=10.1136/bmj.330.7503.1314 |url=}}</ref>
-|<5 yrs
+| style="background:#F5F5F5;" align="center" + |<5 yrs
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-| -
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="left" + |
 * Asymmetrical [[paralysis]]
 * [[Muscle atrophy]]
 * [[Tremors]]
 * [[Skeletal]] deformities
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* History of skipped immunization.
+| style="background:#F5F5F5;" align="left" + |
 * Normal
 * [[Meningeal signs]]
 * Asymmetrical flaccid paralysis
 * Pharyngeal paralysis
-|
+| style="background:#F5F5F5;" align="left" + |
 * Isolation from [[pharyngeal]]<nowiki/>secretions, CSF
-* +Serology
+* Positive serology
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
 * Neurological pattern
 |-
-|Syphilis
+! style="background:#DCDCDC;" align="center" + |[[Syphilis]]<ref name="pmid17235095">{{cite journal |vauthors=French P |title=Syphilis |journal=BMJ |volume=334 |issue=7585 |pages=143–7 |date=January 2007 |pmid=17235095 |pmc=1779891 |doi=10.1136/bmj.39085.518148.BE |url=}}</ref>
-|Variable
+| style="background:#F5F5F5;" align="center" + |Variable
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |Negative
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="left" + |
 * [[Chancre]]
-* Lymphadenopathy
+* [[Lymphadenopathy]]
 * Condylomata lata
-* Neuro syphilis
+* [[Neurosyphilis|Neuro syphilis]]
 * Cardiovascular syphilis
-|
+| style="background:#F5F5F5;" align="left" + |
 * History of risk factors (MSM, unprotected sex, multiple sex partners)
-|
+| style="background:#F5F5F5;" align="left" + |
-* Non-tender [[chancre]] in primary syphilis.
+* Non−tender [[chancre]] in primary syphilis.
 * Followed by [[rash]]
 * Generalized [[lymphadenopathy]] in secondary syphilis
-|
+| style="background:#F5F5F5;" align="left" + |
 * Darkfield examinations
 * VDRL
 * RPR
-* [[FTA-ABS]]
+* [[FTA-ABS|FTA−ABS]]
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
 |-
-|Pyomyositis
+! style="background:#DCDCDC;" align="center" + |[[Pyomyositis]]<ref name="pmid15380499">{{cite journal |vauthors=Crum NF |title=Bacterial pyomyositis in the United States |journal=Am. J. Med. |volume=117 |issue=6 |pages=420–8 |date=September 2004 |pmid=15380499 |doi=10.1016/j.amjmed.2004.03.031 |url=}}</ref>
-|Variable
+| style="background:#F5F5F5;" align="center" + |Variable
-|<nowiki>+/-</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>Distal
-|<nowiki>+/-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-* Fever
+| style="background:#F5F5F5;" align="center" + |−
-* Malaise
+| style="background:#F5F5F5;" align="left" + |
-* Psoas abscess
+* [[Fever]]
-|
+* [[Malaise]]
-* Immunocopmprimised
+* [[Psoas abscess]]
-|
+| style="background:#F5F5F5;" align="left" + |
+* [[Immunocompromised]]
+| style="background:#F5F5F5;" align="left" + |
 ** Muscles are painful, swollen, tender, and indurated.
 ** Depending on the site of involvement, it may mimic appendicitis (psoas muscle), septic arthritis of the hip (iliacus muscle), or epidural abscess (piriformis muscle).
-|
+| style="background:#F5F5F5;" align="left" + |
 * Leukocytosis
 * Elevated ESR
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
-|
+| style="background:#F5F5F5;" align="left" + |
-* -
+* N/A
 |-
-! colspan="16" |Neurologic
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Age of onset
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle weakness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myalgia
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Contractures'''
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gait abnormality
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuropathy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Atrophy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stiffness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myoglobinuria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |History
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Physical
+Examination
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram
 |-
-|ALS
+! rowspan="4" style="background:#DCDCDC;" align="center" + |Neurologic
-|
+! style="background:#DCDCDC;" align="center" + |[[Amyotrophic lateral sclerosis|ALS]]<ref name="pmid26629397">{{cite journal |vauthors=Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A |title=A comprehensive review of amyotrophic lateral sclerosis |journal=Surg Neurol Int |volume=6 |issue= |pages=171 |date=2015 |pmid=26629397 |pmc=4653353 |doi=10.4103/2152-7806.169561 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |>35
-|
+| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>Distal
-|
+* Distal
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-* Both upper and lower motor neuron signs
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Dysphagia]]
+* [[Spasticity]]
+* [[Hyperreflexia]]
+* [[Babinski's sign|Babinski's]] +
+| style="background:#F5F5F5;" align="left" + |
+* N/A
+| style="background:#F5F5F5;" align="left" + |
+* Both [[Upper motor neurons|upper]] and [[lower motor neuron]] signs
+| style="background:#F5F5F5;" align="left" + |
+* Clinical diagnosis
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Nonspecific findings of chronic denervation with reinnervation
-|
+| style="background:#F5F5F5;" align="left" + |
 * Neuropathic
 |-
-|Stroke
+! style="background:#DCDCDC;" align="center" + |[[Stroke]]<ref name="pmid20412000">{{cite journal |vauthors=Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S |title=Acute ischemic stroke update |journal=Pharmacotherapy |volume=30 |issue=5 |pages=493–514 |date=May 2010 |pmid=20412000 |doi=10.1592/phco.30.5.493 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |>65
-* >65
+| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>distal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-* Dysphagia
+| style="background:#F5F5F5;" align="left" + |
+* [[Dysphagia]]
 * Unilateral/Bilateral weakness
-|
+| style="background:#F5F5F5;" align="left" + |
-* H/o HTN, dyslipedemia DM
+* H/o [[Hypertension|HTN]], [[dyslipidaemia]] [[Diabetes mellitus|DM]]
-|
+| style="background:#F5F5F5;" align="left" + |
 * Weakness of the involved arm
-*
+| style="background:#F5F5F5;" align="left" + |
-|
+*Head CT
-*
+| style="background:#F5F5F5;" align="left" + |
-|
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Neuropathic
 |-
-|GBS
+! style="background:#DCDCDC;" align="center" + |[[GBS]]<ref name="pmid23628447">{{cite journal |vauthors=van Doorn PA |title=Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS) |journal=Presse Med |volume=42 |issue=6 Pt 2 |pages=e193–201 |date=June 2013 |pmid=23628447 |doi=10.1016/j.lpm.2013.02.328 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |18  −350
-* 18  -350
+| style="background:#F5F5F5;" align="center" + |Proximal
-| -
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + | −
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
-* Ascending paralysis
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Ascending paralysis]]
-* Precedes a gastrointestinal disease
+| style="background:#F5F5F5;" align="left" + |
-|
+* Precedes a [[Gastrointestinal diseases|gastrointestinal disease]]
+| style="background:#F5F5F5;" align="left" + |
 * Weakness of lower extremities followed by upper extremities
-|
+| style="background:#F5F5F5;" align="left" + |
 * Cytologic albumin ratio
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Normal
-|
+| style="background:#F5F5F5;" align="left" + |
 * Neuropathic
 |-
-|Multiple Sclerosis
+! style="background:#DCDCDC;" align="center" + |[[Multiple sclerosis|Multiple Sclerosis]]<ref name="pmid22605909">{{cite journal |vauthors=Goldenberg MM |title=Multiple sclerosis review |journal=P T |volume=37 |issue=3 |pages=175–84 |date=March 2012 |pmid=22605909 |pmc=3351877 |doi= |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |30's
-|
+| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>distal
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* Ocular findings
-|
+* [[Urinary incontinence]]
-|
+* Problems with [[Speech and language pathology|speech]] or [[swallowing]]
-|
+| style="background:#F5F5F5;" align="left" + |
+* Attacks or exacerbation
+| style="background:#F5F5F5;" align="left" + |
+** Localized weakness
+** Focal sensory disturbances
+** Hyper reactive reflexes
+** Increased tone or stiffness
+| style="background:#F5F5F5;" align="left" + |
+* Head CT ologo−clonal bands
+| style="background:#F5F5F5;" align="left" + |
+* Normal
+| style="background:#F5F5F5;" align="left" + |
+* N/A
+| style="background:#F5F5F5;" align="left" + |
+* Neuropathic
 |-
-! colspan="16" |Neuro-muscular
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Age of onset
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle weakness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myalgia
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Contractures'''
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gait abnormality
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Neuropathy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Atrophy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stiffness
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Myoglobinuria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |History
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Physical
+Examination
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Laboratory Findings
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Creatine Kinase
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Muscle Biopsy
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram
 |-
-|Botulisim
+! rowspan="3" style="background:#DCDCDC;" align="center" + |Neuromuscular
-|
+! style="background:#DCDCDC;" align="center" + |[[Botulinum]]<ref name="pmid15257512">{{cite journal |vauthors=Cherington M |title=Botulism: update and review |journal=Semin Neurol |volume=24 |issue=2 |pages=155–63 |date=June 2004 |pmid=15257512 |doi=10.1055/s-2004-830901 |url=}}</ref>
-|<nowiki>-</nowiki>
+| style="background:#F5F5F5;" align="center" + |Variable
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Distal
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-* H/0 Food exposure and air
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* [[Double vision]]
-|
+* [[Blurred vision]]
-|
+* Drooping eyelids
-|
+* [[Slurred speech]]
+* [[Difficulty swallowing]]
+| style="background:#F5F5F5;" align="left" + |
+* H/O food exposure
+| rowspan="3" style="background:#F5F5F5;" align="left" + |
+* [[Hyporeflexia]]
+* Decreased strength
+| style="background:#F5F5F5;" align="left" + |
+* +Toxin
+| rowspan="3" style="background:#F5F5F5;" align="left" + |
+* Normal
+| rowspan="3" style="background:#F5F5F5;" align="left" + |
+* N/A
+| rowspan="3" style="background:#F5F5F5;" align="left" + |
+* Myopathic
 |-
-|Lambert-Eaton myaes
+! style="background:#DCDCDC;" align="center" + |[[Lambert-Eaton syndrome|Lambert−Eaton syndrome]]<ref name="pmid22094130">{{cite journal |vauthors=Titulaer MJ, Lang B, Verschuuren JJ |title=Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies |journal=Lancet Neurol |volume=10 |issue=12 |pages=1098–107 |date=December 2011 |pmid=22094130 |doi=10.1016/S1474-4422(11)70245-9 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |Variable
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Distal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="center" + | +
-|
+| style="background:#F5F5F5;" align="center" + | +
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* Weakness of the bulbar muscles
-|
+* Ocular
-|
+* Limb weakness
-|
+| style="background:#F5F5F5;" align="left" + |
+* Weaknessa is often relieved temporarily after exertion or physical exercise.
+| style="background:#F5F5F5;" align="left" + |
+* Antibodies against voltage−gated calcium channels
 |-
-|Myasthenia gravis
+! style="background:#DCDCDC;" align="center" + |[[Myasthenia gravis]]<ref name="pmid23193443">{{cite journal |vauthors=Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J |title=Myasthenia gravis: a review |journal=Autoimmune Dis |volume=2012 |issue= |pages=874680 |date=2012 |pmid=23193443 |pmc=3501798 |doi=10.1155/2012/874680 |url=}}</ref>
-|
+| style="background:#F5F5F5;" align="center" + |Variable
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |Proximal
-|<nowiki>+</nowiki>
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + | −
-|
+| style="background:#F5F5F5;" align="center" + | +
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |−
-|
+| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki>
-* Ocular
+| style="background:#F5F5F5;" align="center" + |−
+| style="background:#F5F5F5;" align="left" + |
-* Bulbar
+* [[Ocular]]
+* [[Bulbar]]
 * Limb weakness
 * Isolated neck, limbs and respiratory weakness
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* Weakness often worsens with activity
-|
+| style="background:#F5F5F5;" align="left" + |
-|
+* Antibodies that block or destroy nicotinic [[acetylcholine receptors]]
-|
-|
-|-
-! colspan="16" |Paraneoplastic
-|-
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|-
-! colspan="16" |Metabolic
-|-
-|Glycogen storage disease
-|
-* Variable
-|<nowiki>+</nowiki>
-|<nowiki>-</nowiki>
-|<nowiki>-</nowiki>
-|<nowiki>-</nowiki>
-|<nowiki>-</nowiki>
-|<nowiki>-</nowiki>
-|<nowiki>-</nowiki>
-|
-* AR
-* Faituge
-* Hypoglycemia
-|
-* Exercise intolerance
-|
-* Hypotonia
-* Hepatomeagly
-|
-* Lactic acidosis
-* Elevated liver enzymes
-* [[Ketosis]]
-|
-* '''↑↑'''
-|
-* Normal
-|
-* Normal
-|-
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
-|
 |}

Differentiating Polymyalgia rheumatica from other diseases: Difference between revisions

Revision as of 15:47, 8 May 2018

Overview

Differentiating Polymyalgia Rheumatica from other Diseases

Differentiating polymyalgia rheumatica on the basis of fatigue and chronic pain

Differentiating polymyalgia rheumatica from other causes of myopathy

References

Navigation menu